- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00621075
Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
March 8, 2010 updated by: Northwell Health
Correlation of Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
The goal of our study is to correlate data from non-invasive tests such as perfusion lung scans with hemodynamic measurements from right heart catherizations.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Data collected from PAH patients who have had non-invasive Ventilation/Perfusion testing, Echocardiography, Chest CT Scan, Pulmonary Function Testing and the correlation of those results to the hemodynamic parameters Right Heart Catherization results and the various biomarkers.
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New Hyde Park, New York, United States, 11040
- North Shore-LIJ Health System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Pulmonary Arterial Hypertension
Description
Inclusion Criteria:
- Pulmonary Arterial Hypertension
Exclusion Criteria:
- Non-Pulmonary Arterial Hypertension
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
1
Pulmonary Arterial Hypertension
|
Correlation of data from non-invasive tests such as lung perfusion scans with hemodynamic measurements
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The correlation of patients' hemodynamic parameters with their perfusion index/pulmonary index as measured by ventilation perfusion scans in patients diagnosed with Pulmonary Hypertension.
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Arunabh Talwar, MD, Northwell Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2007
Primary Completion (Actual)
February 1, 2008
Study Completion (Actual)
February 1, 2008
Study Registration Dates
First Submitted
January 17, 2008
First Submitted That Met QC Criteria
February 21, 2008
First Posted (Estimate)
February 22, 2008
Study Record Updates
Last Update Posted (Estimate)
March 9, 2010
Last Update Submitted That Met QC Criteria
March 8, 2010
Last Verified
March 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07.014
- NORTH SHORE IRB
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Arterial Hypertension
-
Vanderbilt University Medical CenterJohns Hopkins UniversityCompletedPulmonary Arterial Hypertension | Idiopathic Pulmonary Arterial Hypertension | Associated Pulmonary Arterial Hypertension | Heritable Pulmonary Arterial HypertensionUnited States
-
American Medical Association FoundationWithdrawnIdiopathic Pulmonary Arterial Hypertension.United States
-
Vanderbilt University Medical CenterRecruitingIdiopathic Pulmonary Arterial Hypertension | Heritable Pulmonary Arterial Hypertension | Scleroderma Associated Pulmonary Arterial Hypertension | Appetite Suppressant Associate PAHUnited States
-
Gachon University Gil Medical CenterChonbuk National University Hospital; Samsung Medical Center; Pusan National... and other collaboratorsUnknownPulmonary Arterial Hypertension | Idiopathic Pulmonary Arterial Hypertension | Deep Phenotyping | Heritable Pulmonary Arterial HypertensionKorea, Republic of
-
Amsterdam UMC, location VUmcZonMw: The Netherlands Organisation for Health Research and DevelopmentUnknown
-
Zhejiang UniversityUnknownIdiopathic Pulmonary Arterial HypertensionChina
-
Association de Recherche en Physiopathologie RespiratoireGlaxoSmithKline; Soladis; InterlisUnknownPulmonary Arterial Hypertension (PAH)France
-
Medical University of GrazLudwig Boltzmann Institute for Lung Vascular ResearchCompletedIdiopathic Pulmonary Arterial HypertensionAustria
-
Zhejiang UniversityCompletedIdiopathic Pulmonary Arterial HypertensionChina
-
Regina Steringer-MascherbauerUnknownPulmonary Arterial Hypertension WHO Group IAustria
Clinical Trials on Pulmonary Arterial Hypertension - Lung Perfusion Scans
-
Hospital Universitari Vall d'Hebron Research InstituteCompletedPulmonary Arterial HypertensionSpain
-
UNC Lineberger Comprehensive Cancer CenterTerminatedThoracic | Pulmonary Injury | Heart InjuriesUnited States
-
Zagazig UniversityRecruitingBacterial Vaginosis | Vaginal | MicrobiologyEgypt
-
University of FloridaUnited TherapeuticsRecruitingInterstitial Lung Disease | Sarcoidosis | Precapillary Pulmonary HypertensionUnited States
-
Centre Hospitalier Princesse GraceCompleted
-
Novartis PharmaceuticalsCompletedCystic FibrosisUnited States
-
Maimónides Biomedical Research Institute of CórdobaUnknown
-
Novartis PharmaceuticalsCompletedBeta Thalassemia Transfusion DependentItaly
-
Novartis PharmaceuticalsCompleted
-
University of Erlangen-Nürnberg Medical SchoolNovartis PharmaceuticalsTerminated